Skip to main content
SpringerLink
Log in

Chinese Experts Consensus on Clinical Application of Naoxintong Capsule (脑心通胶囊)

  • Regulation and Guideline
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wei PF, Zhang SY, Jiao CL. Effect of Naoxintong Capsule on hemorheology of acute blood stasis syndrome in rats. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2003;1:463–465.

    Google Scholar 

  2. Wang H, Zhong WJ, Huang MW, Wu XY, Chen H. Efficacy of dual antiplatelet therapy combined with Naoxintong Capsules following coronary microembolization induced by homologous microthrombi in rats. Chin J Integr Med 2011;17:917–924.

    Article  CAS  PubMed  Google Scholar 

  3. Chen H, Zhang Y, Wu X, Li C, Wang H. In vitro assessment of cytochrome P450 2C19 potential of Naoxintong. Evid Based Complement Alternat Med 2012;2012:430262.

    PubMed  PubMed Central  Google Scholar 

  4. Sun H, Lou XY, Wu XY, Wang H, Qu Q, Tan SL, et al. Up-regulation of CYP2C19 expression by Buchang Naoxintong via PXR activation in HepG2 cells. PLoS One 2016;11:e0160285.

    Google Scholar 

  5. Chen H, Yu GW, Sun H, Wu XY, Wang H. Comparison of adjunctive Naoxintong versus clopidogrel in volunteers with the CYP2 C19 2 gene mutation accompanied with qi deficiency and blood stasis constitution. Evid Based Complement Alternat Med 2011;2011:207034.

    PubMed  PubMed Central  Google Scholar 

  6. Chen H, Wu XY, Wu HX, Wang H. A randomized controlled trial of adjunctive Bunchang Naoxintong Capsule versus maintenance dose clopidogrel in patients with CYP2C19*2 polymorphism. Chin J Integr Med 2014;20:894–902.

    Article  PubMed  Google Scholar 

  7. Zheng YB, Zhang Y, Li CD, Chen H. Effect of Naoxintong Capsule on antithrombotic therapy after percutaneous coronary intervention in 27 cases. J Tradit Chin Med (Chin) 2015;52:299–303.

    Google Scholar 

  8. Yun L, Liu JT, Li XK, Gou Wei, Li JL. Effect of Naoxintong Capsule on acute myocardial ischemia in dogs. Northwest Pharm J (Chin) 2004;19:258–260.

    Google Scholar 

  9. Wang Y, Yan X, Mi S, Li Z, Wang Y, Zhu H, et al. Naoxintong attenuates ischaemia/reperfusion injury through inhibiting NLRP3 inflammasome activation. J Cell Mol Med 2017;21:4–12.

    Article  CAS  PubMed  Google Scholar 

  10. Yang X, Sun L, Li Y, Ma C, Yang J, Zhang W, et al. Naoxintong inhibits the advanced atherosclerosis and enhances the plaque stability in apolipoprotein E deficient mice J. Cardiovasc Pharmacol 2016;67:203–211.

    Article  CAS  Google Scholar 

  11. Dong B, Yu YH, Liu ZZ, Liu Y, Luo M, Zhang J, et al. Exploration on protective effect of Naoxintong on arteriosclerosis in endothelial function of rabbits. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2005;3:328–329.

    Google Scholar 

  12. Dong B, Yu YH, Liu ZZ, Liu Y, Zhang J, Xu XQ, et al. Effect of Naoxintong on MCP-1 gene in experimental arteriosclerosis rabbits. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2005;3:411–412.

    Article  Google Scholar 

  13. Yao J, Xie XL, Xie LD, Wang HJ, Xu CS. Effect of Naoxintong on myocardial fibrosis in spontaneously hypertensive rats. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2008;6:188–190.

    Google Scholar 

  14. Xu H, Jin J, Chen L, Li CX, Xu QG, Shi JJ, et al. Naoxintong/PPAR signaling inhibits H9c2 cell apoptosis and autophagy in response to oxidative stress. Evid Based Complement Alternat Med 2016;2016:4370381.

    PubMed  PubMed Central  Google Scholar 

  15. Liu MT, Liu X, Wang HP, Xiao HB, Jing F, Tang LY, et al. Metabolomics study on the effects of Buchang Naoxintong capsules for treating cerebral ischemia in rats using UPLC-Q/TOF-MS. J Ethnopharmacol 2016;2016:1–11.

    Article  Google Scholar 

  16. Zhang WW, Li YZ, Qiu LQ, Huang YH. Neuroprotective effect of Buchang Naoxintong Capsule on cerebral ischemia reperfusion injury in rats. J Clin Neurol (Chin) 2006;19:118–120.

    Google Scholar 

  17. Xue J, Zhang XJ, Zhang C, Kang N, Liu XX, Yu JY, et al. Protective effect of Naoxintong against cerebral ischemia reperfusion injury in mice. J Ethnopharmacol 2016;182:181–189.

    Article  PubMed  Google Scholar 

  18. Chen J, Lu YQ, Lyu HH. Protective effect of Buchang Naoxintong Capsule on cerebral ischemia reperfusion injury in rats. Chin J Rehabi Theory Pract (Chin) 2009;15:138–140.

    Google Scholar 

  19. Liu SM, He MD, Su NX. Effects of Naoxintong Capsules on behavior and hippocampal morphology in vascular dementia rats. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2006;4:35–36.

    Article  CAS  Google Scholar 

  20. Wei R, He MD, Liu SM, Li H, Wang Z. Effect of Buchang Naoxintong on learning and memory and vascular endothelial growth factor in vascular dementia rats. J Apopl Nerv Dis 2006;23:306–309.

    Google Scholar 

  21. Yang Y, Zeng LX. A meta-analysis of the clinical efficacy and safety of Naoxintong Capsule in the treatment of angina pectoris of coronary heart disease. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2012:4:97–100.

    Google Scholar 

  22. Hou JH, Zhang LL, Li JM, Wang YH, Zheng Y. Meta analysis of the clinical efficacy and safety of Naoxintong Capsule in treatment of unstable angina pectoris. Modern Biomed Progr (Chin) 2014;14:1545–1549.

    Google Scholar 

  23. Na JT, Tang BZ, Yu XY. Effect of Buchang Naoxintong on secondary preventing of 248 cases of myocardial infarction. Harbin Med J (Chin) 2011;31:162–163.

    Google Scholar 

  24. Zhong F, Li W, Li YH. Effect of Naoxintong Capsule on secondary prevention of myocardial infarction. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2014;12:416–418.

    Google Scholar 

  25. Sun YN. Clinical analysis of Naoxintong Capsule in treating 310 cases of cerebral infarction. Chin Pract Med (Chin) 2010;5:164–165.

    Google Scholar 

  26. Sun LH, Zhang C, Yan H, Zeng LX. Meta analysis of efficacy and safety of Naoxintong in treating cerebral infarction. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2012;10:1182–1186.

    Google Scholar 

  27. Li JK. A randomized controlled study of Naoxintong Capsule in treatment of ischemic stroke in acute phase. Shandong Med J (Chin) 2006;46:35–37.

    CAS  Google Scholar 

  28. Ying ZH, Ma LH, Li KJ. Systematic evaluation of Naoxintong Capsule in treating acute ischemic stroke. Shandong Med J (Chin) 2010;29:665–666.

    Google Scholar 

  29. Yang L, Guo Y. Meta analysis of Naoxintong Capsule in treating transient ischemic brain attack. Pharmocol Clin Chin Mater Med (Chin) 2015;31:202–206.

    CAS  Google Scholar 

  30. Liu Y, Yao H. Clinical observation on Naoxintong Capsule in treating vertebra-basilar artery transient ischemic attack. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2009;7:1170–1171.

    Google Scholar 

  31. Shen XZ. Clinical observation on effect of Naoxintong in combination with Western medicine on prevention and treatment of 60 cases of transient ischemic attacks. Chin Pract Med (Chin) 2009;4:147–148.

    Google Scholar 

  32. Deng SL, Zou ZY, Li J. Clinical observation on Naoxintong Capsule in treating senile transient ischemic attack. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2007;5:179–180.

    Google Scholar 

  33. Liu B, Zhang YP. Clinical observation of Buchang Naoxintong on insufficient blood supply of vertebrobasilar artery in senile patients. Chin Pract Med (Chin) 2010;5:137–138.

    Google Scholar 

  34. Wang LQ. Naoxintong Capsule treatment of vertebrobasilar insufficiency in 100 cases. Guangming Tradit Chin Med (Chin) 2011;26:87–88.

    CAS  Google Scholar 

  35. Cheng L. Naoxintong in the treatment of vertebra-basilar insufficiency in 80 cases. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2005;3:1123–1124.

    Google Scholar 

  36. Zhang JL, Jin XQ, Liu Y. Effect of Naoxintong Capsule on clinical symptoms and intima-media thickness in patients with carotid atherosclerosis. Chin J Integr Med Cardio-/Cerebrovasc Dis (Chin) 2006;4:401–402.

    CAS  Google Scholar 

  37. Wen ZY. Effect of Naoxintong Capsules on carotid atherosclerotic plaques. Pract Cardiac Cerebr Pneum Vasc Dis (Chin) 2011;19:41–42.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China

    Liu Long-tao

Authors
  1. Liu Long-tao
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Long-tao, L. Chinese Experts Consensus on Clinical Application of Naoxintong Capsule (脑心通胶囊). Chin. J. Integr. Med. 24, 232–236 (2018). https://doi.org/10.1007/s11655-018-2981-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-018-2981-6

Search

Navigation